Vaccination strategies to control Ebola epidemics in the context of variable household inaccessibility levels
- PMID: 31751337
- PMCID: PMC6894888
- DOI: 10.1371/journal.pntd.0007814
Vaccination strategies to control Ebola epidemics in the context of variable household inaccessibility levels
Abstract
Despite a very effective vaccine, active conflict and community distrust during the ongoing DRC Ebola epidemic are undermining control efforts, including a ring vaccination strategy that requires the prompt immunization of close contacts of infected individuals. However, in April 2019, it was reported 20% or more of close contacts cannot be reached or refuse vaccination, and it is predicted that the ring vaccination strategy would not be effective with such a high level of inaccessibility. The vaccination strategy is now incorporating a "third ring" community-level vaccination that targets members of communities even if they are not known contacts of Ebola cases. To assess the impact of vaccination strategies for controlling Ebola epidemics in the context of variable levels of community accessibility, we employed an individual-level stochastic transmission model that incorporates four sources of heterogeneity: a proportion of the population is inaccessible for contact tracing and vaccination due to lack of confidence in interventions or geographic inaccessibility, two levels of population mixing resembling household and community transmission, two types of vaccine doses with different time periods until immunity, and transmission rates that depend on spatial distance. Our results indicate that a ring vaccination strategy alone would not be effective for containing the epidemic in the context of significant delays to vaccinating contacts even for low levels of household inaccessibility and affirm the positive impact of a supplemental community vaccination strategy. Our key results are that as levels of inaccessibility increase, there is a qualitative change in the effectiveness of the vaccination strategy. For higher levels of vaccine access, the probability that the epidemic will end steadily increases over time, even if probabilities are lower than they would be otherwise with full community participation. For levels of vaccine access that are too low, however, the vaccination strategies are not expected to be successful in ending the epidemic even though they help lower incidence levels, which saves lives, and makes the epidemic easier to contain and reduces spread to other communities. This qualitative change occurs for both types of vaccination strategies: ring vaccination is effective for containing an outbreak until the levels of inaccessibility exceeds approximately 10% in the context of significant delays to vaccinating contacts, a combined ring and community vaccination strategy is effective until the levels of inaccessibility exceeds approximately 50%. More broadly, our results underscore the need to enhance community engagement to public health interventions in order to enhance the effectiveness of control interventions to ensure outbreak containment.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures










Similar articles
-
Effectiveness of Ring Vaccination as Control Strategy for Ebola Virus Disease.Emerg Infect Dis. 2016 Jan;22(1):105-8. doi: 10.3201/eid2201.151410. Emerg Infect Dis. 2016. PMID: 26691346 Free PMC article.
-
Ebola Outbreak Response in the DRC with rVSV-ZEBOV-GP Ring Vaccination.N Engl J Med. 2024 Dec 19;391(24):2327-2336. doi: 10.1056/NEJMoa1904387. N Engl J Med. 2024. PMID: 39693543
-
Spatiotemporal dynamics of the Ebola epidemic in Guinea and implications for vaccination and disease elimination: a computational modeling analysis.BMC Med. 2016 Sep 7;14(1):130. doi: 10.1186/s12916-016-0678-3. BMC Med. 2016. PMID: 27600737 Free PMC article.
-
Ebola Virus: Pathogenesis and Countermeasure Development.Annu Rev Virol. 2019 Sep 29;6(1):435-458. doi: 10.1146/annurev-virology-092818-015708. Annu Rev Virol. 2019. PMID: 31567063 Review.
-
Considerations for use of Ebola vaccine during an emergency response.Vaccine. 2019 Nov 15;37(48):7190-7200. doi: 10.1016/j.vaccine.2017.08.058. Epub 2017 Sep 7. Vaccine. 2019. PMID: 28890191 Free PMC article. Review.
Cited by
-
Monkeypox and Its Possible Sexual Transmission: Where Are We Now with Its Evidence?Pathogens. 2022 Aug 17;11(8):924. doi: 10.3390/pathogens11080924. Pathogens. 2022. PMID: 36015044 Free PMC article. Review.
-
Picking up a Fight: Fine Tuning Mitochondrial Innate Immune Defenses Against RNA Viruses.Front Microbiol. 2020 Aug 31;11:1990. doi: 10.3389/fmicb.2020.01990. eCollection 2020. Front Microbiol. 2020. PMID: 32983015 Free PMC article. Review.
-
Current state of Ebola virus vaccines: A snapshot.PLoS Pathog. 2021 Dec 9;17(12):e1010078. doi: 10.1371/journal.ppat.1010078. eCollection 2021 Dec. PLoS Pathog. 2021. PMID: 34882741 Free PMC article. No abstract available.
-
Mpox in Central Africa: complex epidemiology requires a constellation approach.Npj Viruses. 2024 Dec 30;2(1):69. doi: 10.1038/s44298-024-00081-x. Npj Viruses. 2024. PMID: 40295713 Free PMC article.
-
Perceptions and Rumors About the Ebola Virus Disease Vaccine in the Ituri and Kivu Provinces of the Democratic Republic of Congo.J Immunol Sci. 2023 May 12;Suppl 3:58-68. doi: 10.29245/2578-3009/2023/S3.1111. J Immunol Sci. 2023. PMID: 38333356 Free PMC article.
References
-
- Yong E. (2019). The WHO Finally Sounds Its Loudest Alarm Over Ebola in the Congo. The Atlantic. Science.
-
- Frontieres M. S. (2019). Ebola outbreak in Democratic Republic of Congo Fighting an epidemic in a conflict zone. MSF Doctors Without Borders.
-
- 2014 Ebola Outbreak in West Africa—Reported Cases Graphs 2016 [cited 2017 March 23]. Available from: https://www.cdc.gov/vhf/ebola/outbreaks/2014-west-africa/cumulative-case....
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous